1. E-mail: daniceandrus@att.net • Cel: (925) 922-2917
Danice M. Andrus
Objective
Seeking a position that utilizes my skill as a program manager.
Professional experience
April 2013-present BIOVIA at Dassault Systémes
Sr Project Manager
Accomplishments
Technical and communications support officer for our sourcing database suppliers
First-line management of virtual machines (vms) to troubleshoot connectivity issues
Manage budget, invoices, and vendor/consultant contracts for Content Group
Participated in cross-functional teams which included CISPro management, marketing,
sales, and customer support to improve Content products, and integrate our content with
CISPro products
Travel-Interface directly with Content suppliers at various conferences twice a year
Manage international outsource partners across multiple platforms
Chemical informatics, Extract/Transform/Load (ETL) supplier data for inclusion in our
sourcing databases
Principle contributor-product releases, primarily, All Chemicals Directory (ACD)
Database Administrator-MDL Drug Data Report (MDDR) database, collaboration with
Prous Science
Procurement of GHS/SDS/DSD data for inclusion in our sourcing database products
Mar 2005-Mar 2013 Accelrys, Inc.
Sr Scientific Editor
Accomplishments
Created outsourcing teams for daily ACD workflow
Generated and maintained training Documentation
Chemical informatics, Extract/Transform/Load (ETL) supplier data for inclusion in our
sourcing databases
Principle contributor to monthly ACD release
Database Administrator-Toxicity, RTECS, and MDDR
Technical advisor for Content suppliers
May 2004-Feb. 2005 Acenta Discovery, Inc.
Chemist
Accomplishments
Targeted multi-step synthesis of Caspase-3 inhibitors
Scale-up to multi-gram preparations
2. Education
May 2004 University of Arizona
M.S. Chemistry, Research Director-Prof. Victor J. Hruby
Dissertation Title
The Design and Synthesis of Imino-Bridged Cyclic Peptides and The Internal Synthesis of
Beta-Turn Mimetics in Solid Phase Peptide Synthesis
Project 1
Synthesis of novel [3.3.0]-Beta-turn peptidomimetics to mimic the mechanism of action of
endogenous leu-enkephalins in constrained, rigid substrates that can be used to probe the
opioid receptor system for improved analgesia effects.
Project 2
Utilizing imine formation to cyclize peptides as a pilot study for the formation of
nostocyclopeptolides, naturally occurring 21-membered cyclic imino-peptides.
August 1988 Indiana University
B.S. Biochemistry
May 1981 Vincennes University
A.A. Pre-Medicine
Skills
Chemical Informatics, Database Administration, MySQL programming, Unix, Outsourcing,
Documentation, Budget, Communications, Accounting, Cross-functional teams, Targeted
synthesis using multi-step strategies, Scale-up, Small molecule synthetic chemist, peptide
chemist, NMR, IR, MS, GC, GC/MS, HPLC, binding assays for Alpha1, Alpha2, 5-HT1, 5-
HT2, 5-HT3, D1, and D2 receptors, serotonin uptake studies, pharmacological behavioral
studies, teaching, technical training, supervisor of teaching assistants and student workers,
website creation using FrontPage, JavaScript, and HTML, database creation and maintenance
Patents and publications
An Introduction to the Chemical Laboratory for Allied Health Professionals (2009), Steve Brown and
Danice Andrus, Hayden McNeil
Andrus, D. 2004 The Design and Synthesis of Imine-Bridged Cyclic Peptides and the Solid Phase
Synthesis of -Turn Mimetics, M.S. Thesis, University of Arizona
Gu, Xuyuan; Vagner, Joseph; Andrus, Danice; Stankova, Magda; Hruby, Victor J., New Methodology
for Syntheses of Bicyclic -Turn Dipeptides (BTD) on Solid Phase Supports, Peptide Revolution:
Genomics, Proteomics & Therapeutics, Chorev, Michael & Sawyer, Tomi K., American Peptide
Society, 2003.
Reyes-Parada, Miguel; Scorza, Cecilia; Romero, Veronica; Silveira, Rodolfo; Medina, Jorge H.;
Andrus, Danice; Nichols, David E.; Cassels, Bruce K., (+/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-
aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites
and serotonin-1A receptors, Naunyn-Schmiedeberg's Archives of Pharmacology (1996), 354(5), 579-
585